{"id":210872,"date":[{"year":1951,"month":1,"day":10}],"page":"5","source":"","region":"","masthead":"","special_issue":"","column":"读者接待室,医药顾问","genre":"","count":"366","ytitle":"","mtitle":"“结核安”的效用?","ftitle":"","authors":["唐慎齐"],"text":[{"type":"paragraph","text":"(答)汪德康先生:"},{"type":"paragraph","text":"所询有关‘结核安’之问题我简答如下:"},{"type":"paragraph","text":"一、T，B，One对早期渗 液型病例据德国专家报告似最有效，但对于慢性结核病例其效不著，奏效者仅28%，奏效显著者仅5%。"},{"type":"paragraph","text":"二、该药之内服剂量德国临床家意见，尚未一致，有主张每日量为0.0125至0.025gm.有的主张用0.1-0。3gm.一般标准则于最初一一一二星期内，每日自0.025公分逐渐增至0.1-0.2公分，此种每日量可一次顿服(小剂量时)或分作二一一四次内服亦可(因为大剂量以分服可较少反应)但此药因毒性甚大故必须请医师指导使用为要。"},{"type":"paragraph","text":"三、目前尚无很妥善之防制副作用方法，如由医师指导下使用，当然可以避免不必要之不良反应发生。"},{"type":"paragraph","text":"四、该药之毒性反应甚多，主要是人类对该药之忍受性甚小，至于破坏了些什么，无法在此详述。"},{"type":"paragraph","text":"唐慎斋医师答"}]}